Mustang Bio, Inc. announced that it will receive $4,742,942 in funding on October 26, 2023. The company will issue convertible preferred stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5553 USD | -0.93% |
|
+327.15% | -58.87% |
03:13pm | Sector Update: Health Care Stocks Steady Premarket Friday | MT |
Jun. 20 | Mustang Bio to Raise $2.5 Million From Share Offering | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.87% | 15.79M | |
+15.19% | 122B | |
+19.91% | 113B | |
+8.24% | 22.84B | |
-19.80% | 20.72B | |
-16.19% | 16.51B | |
-13.45% | 16.39B | |
-44.35% | 15.83B | |
+2.13% | 13.49B | |
+66.67% | 11.67B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. announced that it expects to receive $4.742942 million in funding